APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Group ACYW135 Meningococcal Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032

Report ID 173996380230 December 2025194 pages

Choose your research edition.

Industry ResearchGroup ACYW135 Meningococcal Polysaccharide Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Group ACYW135 Meningococcal Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Group ACYW135 Meningococcal Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Group ACYW135 Meningococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Group ACYW135 Meningococcal Polysaccharide Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine include Zhejiang Tianyuan Biopharmaceutical Co., Ltd, Yuxi Watson Biotechnology Co., Ltd, CanSino Biologics AG, Hualan Biovaccine Co., Ltd, Chengdu Kanghua Biological Products Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd, Beijing Institute of Biological Products Co., Ltd, Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd and Walvax Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Group ACYW135 Meningococcal Polysaccharide Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Group ACYW135 Meningococcal Polysaccharide Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Group ACYW135 Meningococcal Polysaccharide Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Group ACYW135 Meningococcal Polysaccharide Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Group ACYW135 Meningococcal Polysaccharide Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Group ACYW135 Meningococcal Polysaccharide Vaccine sales, projected growth trends, production technology, application and end-user industry.

Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Company

Zhejiang Tianyuan Biopharmaceutical Co., Ltd

Yuxi Watson Biotechnology Co., Ltd

CanSino Biologics AG

Hualan Biovaccine Co., Ltd

Chengdu Kanghua Biological Products Co., Ltd

Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd

Beijing Institute of Biological Products Co., Ltd

Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd

Walvax Biotechnology

Sanofi-Pasteur

Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Type

Class I Vaccines

Class II Vaccines

Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Application

Hospital

Clinic

Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Group ACYW135 Meningococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Group ACYW135 Meningococcal Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Group ACYW135 Meningococcal Polysaccharide Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Group ACYW135 Meningococcal Polysaccharide Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Class I Vaccines Major Manufacturers Table 3. Class II Vaccines Major Manufacturers Table 4. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Trends Table 8. Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Drivers Table 9. Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Opportunities and Challenges Table 10. Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Restraints Table 11. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (K Units) Table 18. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (K Units) Table 19. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers, Product Type & Application Table 29. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Group ACYW135 Meningococcal Polysaccharide Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 39. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 40. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2021-2026) & (US$/Unit) Table 43. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2027-2032) & (US$/Unit) Table 44. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 51. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 52. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2021-2026) & (US$/Unit) Table 55. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2027-2032) & (US$/Unit) Table 56. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Company Information Table 57. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Business Overview Table 58. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 60. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Development Table 61. Yuxi Watson Biotechnology Co., Ltd Company Information Table 62. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 63. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 65. Yuxi Watson Biotechnology Co., Ltd Recent Development Table 66. CanSino Biologics AG Company Information Table 67. CanSino Biologics AG Business Overview Table 68. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 70. CanSino Biologics AG Recent Development Table 71. Hualan Biovaccine Co., Ltd Company Information Table 72. Hualan Biovaccine Co., Ltd Business Overview Table 73. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 75. Hualan Biovaccine Co., Ltd Recent Development Table 76. Chengdu Kanghua Biological Products Co., Ltd Company Information Table 77. Chengdu Kanghua Biological Products Co., Ltd Business Overview Table 78. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 80. Chengdu Kanghua Biological Products Co., Ltd Recent Development Table 81. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information Table 82. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview Table 83. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 85. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Development Table 86. Beijing Institute of Biological Products Co., Ltd Company Information Table 87. Beijing Institute of Biological Products Co., Ltd Business Overview Table 88. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 90. Beijing Institute of Biological Products Co., Ltd Recent Development Table 91. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Company Information Table 92. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Business Overview Table 93. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 95. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Development Table 96. Walvax Biotechnology Company Information Table 97. Walvax Biotechnology Business Overview Table 98. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 100. Walvax Biotechnology Recent Development Table 101. Sanofi-Pasteur Company Information Table 102. Sanofi-Pasteur Business Overview Table 103. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 105. Sanofi-Pasteur Recent Development Table 106. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 107. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 108. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 109. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 110. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 111. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 112. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 115. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 116. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 117. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 118. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 122. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 123. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 124. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 125. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 126. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 127. Canada Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 128. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 131. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 132. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 133. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 134. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 137. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 138. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 139. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 140. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 144. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 145. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 146. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 147. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 148. Germany Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 149. France Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 150. U.K. Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 151. Italy Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 153. China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 154. China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 155. China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 156. China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 157. China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 158. China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 159. China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 160. China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 161. China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 162. China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 163. China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 164. China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 165. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 166. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 167. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 168. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 169. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 170. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 171. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 172. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 173. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 174. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 175. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 176. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 182. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 183. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 184. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 186. South Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 187. India Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 188. Australia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 189. China Taiwan Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 190. Southeast Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 191. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 192. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 193. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 194. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 195. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 196. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 197. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 198. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 199. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 200. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 201. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 202. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 203. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 207. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 208. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 209. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 210. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 211. Brazil Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Argentina Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Chile Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Colombia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Peru Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Saudi Arabia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Israel Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 218. UAE Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 219. Turkey Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Iran Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Egypt Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Key Raw Materials Table 223. Raw Materials Key Suppliers Table 224. Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors List Table 225. Group ACYW135 Meningococcal Polysaccharide Vaccine Customers List Table 226. Research Programs/Design for This Report Table 227. Authors List of This Report Table 228. Secondary Sources Table 229. Primary Sources List of Figures Figure 1. Group ACYW135 Meningococcal Polysaccharide Vaccine Image Figure 2. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Class I Vaccines Image Figure 5. Class II Vaccines Image Figure 6. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (2021-2032) & (K Units) Figure 16. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Group ACYW135 Meningococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Group ACYW135 Meningococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 40. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 42. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 50. China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 51. China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 52. China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 53. China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Group ACY

Scope & coverage.

Types
  • Class I Vaccines
  • Class II Vaccines
Applications
  • Hospital
  • Clinic
Companies covered
  • Zhejiang Tianyuan Biopharmaceutical Co., Ltd
  • Yuxi Watson Biotechnology Co., Ltd
  • CanSino Biologics AG
  • Hualan Biovaccine Co., Ltd
  • Chengdu Kanghua Biological Products Co., Ltd
  • Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  • Beijing Institute of Biological Products Co., Ltd
  • Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
  • Walvax Biotechnology
  • Sanofi-Pasteur

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market by Type
  3. 1.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Class I Vaccines
  5. 1.2.3 Class II Vaccines
  6. 1.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Market by Application
  7. 1.3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Dynamics
  1. 2.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Trends
  2. 2.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Drivers
  3. 2.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region
  3. 3.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region
  9. 3.4.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Manufacturers
  6. 4.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Group ACYW135 Meningococcal Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
5 Group ACYW135 Meningococcal Polysaccharide Vaccine Market by Type
  1. 5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type
  2. 5.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
  6. 5.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type
6 Group ACYW135 Meningococcal Polysaccharide Vaccine Market by Application
  1. 6.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application
  2. 6.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
  6. 6.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application
7 Company Profiles
  1. 7.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd
  2. 7.1.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Company Information
  3. 7.1.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Business Overview
  4. 7.1.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  6. 7.1.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments
  7. 7.2 Yuxi Watson Biotechnology Co., Ltd
  8. 7.2.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  9. 7.2.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  10. 7.2.3 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  12. 7.2.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
  13. 7.3 CanSino Biologics AG
  14. 7.3.1 CanSino Biologics AG Company Information
  15. 7.3.2 CanSino Biologics AG Business Overview
  16. 7.3.3 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  18. 7.3.5 CanSino Biologics AG Recent Developments
  19. 7.4 Hualan Biovaccine Co., Ltd
  20. 7.4.1 Hualan Biovaccine Co., Ltd Company Information
  21. 7.4.2 Hualan Biovaccine Co., Ltd Business Overview
  22. 7.4.3 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  24. 7.4.5 Hualan Biovaccine Co., Ltd Recent Developments
  25. 7.5 Chengdu Kanghua Biological Products Co., Ltd
  26. 7.5.1 Chengdu Kanghua Biological Products Co., Ltd Company Information
  27. 7.5.2 Chengdu Kanghua Biological Products Co., Ltd Business Overview
  28. 7.5.3 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  30. 7.5.5 Chengdu Kanghua Biological Products Co., Ltd Recent Developments
  31. 7.6 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  32. 7.6.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information
  33. 7.6.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview
  34. 7.6.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  36. 7.6.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments
  37. 7.7 Beijing Institute of Biological Products Co., Ltd
  38. 7.7.1 Beijing Institute of Biological Products Co., Ltd Company Information
  39. 7.7.2 Beijing Institute of Biological Products Co., Ltd Business Overview
  40. 7.7.3 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  42. 7.7.5 Beijing Institute of Biological Products Co., Ltd Recent Developments
  43. 7.8 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
  44. 7.8.1 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Company Information
  45. 7.8.2 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Business Overview
  46. 7.8.3 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  48. 7.8.5 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments
  49. 7.9 Walvax Biotechnology
  50. 7.9.1 Walvax Biotechnology Company Information
  51. 7.9.2 Walvax Biotechnology Business Overview
  52. 7.9.3 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  54. 7.9.5 Walvax Biotechnology Recent Developments
  55. 7.10 Sanofi-Pasteur
  56. 7.10.1 Sanofi-Pasteur Company Information
  57. 7.10.2 Sanofi-Pasteur Business Overview
  58. 7.10.3 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  60. 7.10.5 Sanofi-Pasteur Recent Developments
8 North America
  1. 8.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type
  2. 8.1.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 8.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application
  6. 8.2.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 8.3 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
  10. 8.3.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type
  2. 9.1.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application
  6. 9.2.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
  10. 9.3.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type
  2. 10.1.1 China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 10.2 China Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application
  6. 10.2.1 China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type
  2. 11.1.1 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application
  6. 11.2.1 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
  10. 11.3.1 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type
  2. 12.1.1 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application
  6. 12.2.1 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
  10. 12.3.1 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Value Chain Analysis
  2. 13.1.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Production Mode & Process
  6. 13.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors
  9. 13.2.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst